Evidence map›Paper›PMID 36561916›Full record

ArticleFrontiers in neurorobotics2022

Transformer-based progressive residual network for single image dehazing.

Zhe Yang, Xiaoling Li, Jinjiang Li

Abstract read
In one paragraph

Article in Frontiers in neurorobotics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhe YangSchool of Computer Science and Technology, Intgrow Education Technology, Qingdao Vocational and Technical College of Hotel Management, Shandong Technology and Business University, Yantai, China.
Xiaoling LiSchool of Computer Science and Technology, Intgrow Education Technology, Qingdao Vocational and Technical College of Hotel Management, Shandong Technology and Business University, Yantai, China.
Jinjiang LiSchool of Computer Science and Technology, Intgrow Education Technology, Qingdao Vocational and Technical College of Hotel Management, Shandong Technology and Business University, Yantai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The seriously degraded fogging image affects the further visual tasks. How to obtain a fog-free image is not only challenging, but also important in computer vision. Recently, the vision transformer (ViT) architecture has achieved very efficient performance in several vision areas. Methods: In this paper, we propose a new transformer-based progressive residual network. Different from the existing single-stage ViT architecture, we recursively call the progressive residual network with the introduction of swin transformer. Specifically, our progressive residual network consists of three main components: the recurrent block, the transformer codecs and the supervise fusion module. First, the recursive block learns the features of the input image, while connecting the original image features of the original iteration. Then, the encoder introduces the swin transformer block to encode the feature representation of the decomposed block, and continuously reduces the feature mapping resolution to extract remote context features. The decoder recursively selects and fuses image features by combining attention mechanism and dense residual blocks. In addition, we add a channel attention mechanism between codecs to focus on the importance of different features. Results and discussion: The experimental results show that the performance of this method outperforms state-of-the-art handcrafted and learning-based methods.

Indexed as

image dehazingmultiple self-attentionprogressive recurrentresidual networktransformer

Identifiers

PMID36561916
PMCPMC9766349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.